Gordon Dunn - Net Worth and Insider Trading

Gordon Dunn Net Worth

The estimated net worth of Gordon Dunn is at least $17,891 dollars as of 2024-11-13. Gordon Dunn is the CFO of Quoin Pharmaceuticals Ltd and owns about 28,856 shares of Quoin Pharmaceuticals Ltd (QNRX) stock worth over $17,891. Details can be seen in Gordon Dunn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gordon Dunn has not made any transactions after 2024-09-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gordon Dunn

To

Gordon Dunn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gordon Dunn owns 1 companies in total, including Quoin Pharmaceuticals Ltd (QNRX) .

Click here to see the complete history of Gordon Dunn’s form 4 insider trades.

Insider Ownership Summary of Gordon Dunn

Ticker Comapny Transaction Date Type of Owner
QNRX Quoin Pharmaceuticals Ltd 2024-09-10 Chief Financial Officer

Gordon Dunn Latest Holdings Summary

Gordon Dunn currently owns a total of 1 stock. Gordon Dunn owns 28,856 shares of Quoin Pharmaceuticals Ltd (QNRX) as of September 10, 2024, with a value of $17,891.

Latest Holdings of Gordon Dunn

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
QNRX Quoin Pharmaceuticals Ltd 2024-09-10 28,856 0.62 17,891

Holding Weightings of Gordon Dunn


Gordon Dunn Form 4 Trading Tracker

According to the SEC Form 4 filings, Gordon Dunn has made a total of 1 transactions in Quoin Pharmaceuticals Ltd (QNRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Quoin Pharmaceuticals Ltd is the acquisition of 28,856 shares on September 10, 2024, which cost Gordon Dunn around $23,085.

Insider Trading History of Gordon Dunn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gordon Dunn Trading Performance

GuruFocus tracks the stock performance after each of Gordon Dunn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gordon Dunn is %. GuruFocus also compares Gordon Dunn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gordon Dunn within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gordon Dunn's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gordon Dunn

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -24.4 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -29.58 LIMIT LIMIT LIMIT LIMIT LIMIT

Gordon Dunn Ownership Network

Ownership Network List of Gordon Dunn

No Data

Ownership Network Relation of Gordon Dunn

Insider Network Chart

Gordon Dunn Owned Company Details

What does Quoin Pharmaceuticals Ltd do?

Who are the key executives at Quoin Pharmaceuticals Ltd?

Gordon Dunn is the Chief Financial Officer of Quoin Pharmaceuticals Ltd. Other key executives at Quoin Pharmaceuticals Ltd include director & Chief Operating Officer Denise P. Carter , and director & Chief Executive Officer Michael Myers .

Quoin Pharmaceuticals Ltd (QNRX) Insider Trades Summary

Over the past 18 months, Gordon Dunn made 1 insider transaction in Quoin Pharmaceuticals Ltd (QNRX) with a net purchase of 28,856. Other recent insider transactions involving Quoin Pharmaceuticals Ltd (QNRX) include a net purchase of 37,894 shares made by Michael Myers , a net purchase of 37,735 shares made by Denise P. Carter , and a net sale of 297 shares made by Dennis Langer .

In summary, during the past 3 months, insiders sold 0 shares of Quoin Pharmaceuticals Ltd (QNRX) in total and bought 104,485 shares, with a net purchase of 104,485 shares. During the past 18 months, 297 shares of Quoin Pharmaceuticals Ltd (QNRX) were sold and 104,485 shares were bought by its insiders, resulting in a net purchase of 104,188 shares.

Quoin Pharmaceuticals Ltd (QNRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Quoin Pharmaceuticals Ltd Insider Transactions

No Available Data

Gordon Dunn Mailing Address

Above is the net worth, insider trading, and ownership report for Gordon Dunn. You might contact Gordon Dunn via mailing address: Azrieli Center, Round Tower, Ter Aviv L3 6701101.